oral semaglutide weight loss studies 50 mg of #semaglutide daily was associated with body reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://ja.ma/41sPiYj Why Injectable Semaglutide Remains Superior:

Its front-and-center in a lot of employees lives. Access bonus Workspan Daily Plus+ content on this subject: Increasing Demand Poses Expensive Deliberations Among the nearly 300 employers surveyed by the IFEBP for a recent study, 34% are now covering GLP-1 drugs for both diabetes management and weight loss, up 8 percentage points from 12 months ago

Raufman and his colleagues published their findings and talked about it at conferences

Semaglutide, a GLP-1 receptor agonist, primarily works by mimicking a hormone in the body that reduces hunger

8 The Bristol-Myers Squibb-Pfizer Alliance is pleased with the decision by the U.S

, CJC-1295 FRAGMENT 176-191

Short-Term Productivity and Presenteeism Gains While long-term cost savings from reducing obesity-related conditions are clear, employers also see immediate productivity improvements